By Angela McDaniels
Tacoma, Wash., March 11 - CareFusion Corp. priced $300 million of 3.3% senior notes due 2023 at 99.908, according to an 8-K filing with the Securities and Exchange Commission.
The notes (Baa3/BBB/BBB) were priced under Rule 144A and Regulation S.
The bookrunners are BofA Merrill Lynch, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC.
Prior to Dec. 1, 2022, the company has a make-whole call option at Treasuries plus 25 basis points. Beginning Dec. 1, 2022, the notes are callable at par.
There is a put option at 101% of par in the event of a change of control.
Proceeds will be used for general corporate purposes.
CareFusion is a San Diego-based provider of medical products and services.
| Issuer: | CareFusion Corp.
|
| Issue: | Senior notes
|
| Amount: | $300 million
|
| Proceeds: | $298 million
|
| Maturity: | 2023
|
| Bookrunners: | BofA Merrill Lynch, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC
|
| Coupon: | 3.3%
|
| Price: | 99.908
|
| Call option: | Make-whole call option at Treasuries plus 25 bps prior to Dec. 1, 2022; callable at par after that
|
| Put option: | At 101 upon a change of control
|
| Pricing date: | March 11
|
| Ratings: | Moody's: Baa3
|
| Standard & Poor's: BBB
|
| Fitch: BBB
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
